Anavex Life Sciences Corp (AVXL)

[Gator328]

Possible, but unlikely. Mallinkrodt just received RMAT today and its drug was in the middle of P3 testing.

273 on its face appears to be the perfect candidate for RMAT, but I think the current trial design and limited number of enrollees will make that a difficult pitch, even for someone as connected as Dr. Fadrian.

What I still don't get is the impatience here. Everyone thinks this is taking forever because they've held the stock for 2.5 years. Finding a new treatment for Alzheimer's is the scientific equivalent of the moon landing. It's going to take time to find the right way to do it, and there may be lots of failed trials along the way.

I'm content to sit back and just assume that 273 is going to run its natural course with the standard FDA approval process